These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 2240054

  • 1. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D, Czarnecki M, Donati D, Homer L, Eisinger RP, Raska K, Raskova J.
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [Abstract] [Full Text] [Related]

  • 2. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
    Petersen J, Moore RM, Kaczmarek RG, Singh B, Yeh I, Hamburger S, Kankam M.
    Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
    [Abstract] [Full Text] [Related]

  • 3. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM, Freitas LA, Alves VC, Garção MF, Rosa MA, Marques AA.
    Am J Nephrol; 2001 Feb; 21(4):264-73. PubMed ID: 11509797
    [Abstract] [Full Text] [Related]

  • 4. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
    Moczulski D, Zukowska-Szczechowska E, Grzeszczak W, Religa Z, Cichoń R, Szydłowska I.
    Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
    [Abstract] [Full Text] [Related]

  • 5. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM, Kandell NF, El-Shamaa AA, Harba TM, Abdel-Hady AA.
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [Abstract] [Full Text] [Related]

  • 6. [The effect of repeated use of cuprophane and polysulfone dialyzers during hemodialysis on the count of natural killer cells in blood].
    Liszka M, Moczulski D, Zukowska-Szczechowska E, Grzeszczak W, Religa Z.
    Pol Arch Med Wewn; 1997 Mar; 97(3):224-31. PubMed ID: 9333768
    [Abstract] [Full Text] [Related]

  • 7. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study.
    Gastaldello K, Melot C, Kahn RJ, Vanherweghem JL, Vincent JL, Tielemans C.
    Nephrol Dial Transplant; 2000 Feb; 15(2):224-30. PubMed ID: 10648669
    [Abstract] [Full Text] [Related]

  • 8. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA, Woffindin C, Cox PJ, Goldfinch M, Roberts SJ.
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [Abstract] [Full Text] [Related]

  • 9. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E, Moczulski D, Grzeszczak W, Gosek K, Augustyn M, Staszewicz P.
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [Abstract] [Full Text] [Related]

  • 10. Ex vivo flow cytometry determination of intracytoplasmic expression of IL-2, IL-6, IFN-gamma, and TNF-alpha in monocytes and T lymphocytes, in chronic hemodialysis patients.
    Rostaing L, Peres C, Tkaczuk J, Charlet JP, Bories P, Durand D, Ohayon E, de Préval C, Abbal M.
    Am J Nephrol; 2000 Nov; 20(1):18-26. PubMed ID: 10644863
    [Abstract] [Full Text] [Related]

  • 11. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C, Heintz B, Sieberth HG.
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [Abstract] [Full Text] [Related]

  • 12. Comprehensive evaluation of acute immunological changes induced by cuprophane and polysulfone membranes in a patient on chronic hemodialysis.
    Patarca R, Perez G, Gonzalez A, Garcia-Morales RO, Gamble R, Klimas N, Fletcher MA.
    Am J Nephrol; 1992 Nov; 12(4):274-8. PubMed ID: 1481878
    [Abstract] [Full Text] [Related]

  • 13. High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis.
    Küchle C, Fricke H, Held E, Schiffl H.
    Am J Nephrol; 1996 Nov; 16(6):484-8. PubMed ID: 8955759
    [Abstract] [Full Text] [Related]

  • 14. Biocompatibility of high-flux membranes.
    Putz D, Barnas U, Luger A, Mayer G, Woloszczuk W, Graf H.
    Int J Artif Organs; 1992 Aug; 15(8):456-60. PubMed ID: 1399092
    [Abstract] [Full Text] [Related]

  • 15. Apoptotic markers on lymphocytes and monocytes are unchanged during single hemodialysis sessions using either regenerated cellulose or polysulfone membranes.
    Wu CC, Liao TN, Lu KC, Chen JS, Chu P, Lin SH, Chuang CH, Lin YF.
    Clin Nephrol; 2005 Sep; 64(3):198-204. PubMed ID: 16175944
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro study.
    Donati D, Degiannis D, Homer L, Raska K, Raskova J.
    Am J Nephrol; 1991 Sep; 11(6):451-8. PubMed ID: 1819211
    [Abstract] [Full Text] [Related]

  • 18. Removal of beta 2-microglobulin by hemodialysis and hemofiltration: a four year follow up.
    Schiffl H, D'Agostini B, Held E.
    Biomater Artif Cells Immobilization Biotechnol; 1992 Sep; 20(5):1223-32. PubMed ID: 1457695
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.